Terms ending in 2031
Every in-force patent on F. Hoffmann-La Roche AG's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,512,983 | Production of Proteins in Glutamine-Free Cell Culture Media In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 9,200,071 | Methods of Treating Cancer Using NOTCH1 and NOTCH3 Antagonists In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US D776,271 | Medical Protective Shield In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 8,404,239 | ANTI-NOTCH2 NRR Antibodies In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 10,501,411 | Substituted Benzamides In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,399,670 | Method for Obtaining Immunoglobulin Encoding Nucleic Acid In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,587,006 | Igf-I Poly (Ethylene Glycol) Conjugates In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,499,624 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 8,227,491 | 5-(3,4-Dichloro-PHENYL)-N-(2-Hydroxy-CYCLOHEXYL)-6-(2,2,2-Trifluoro-ETHOXY)-NICOTINAMIDE and Salts Thereof In force · High confidence | Hoffmann-La Roche, Inc. | In force | High confidence | |
| US 9,073,911 | Pyrazole Derivatives In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 32 more term ends in 2031 · Pro | |||||
10 of 42 patents shown. Soonest term end first, then patent number.
Pro members see all 42.
15 of these are in force and held by F. Hoffmann-La Roche AG.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.